Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Rowland Insider Profile
4 Followers
Charles Rowland, Director at DNIB Unwind, Inc., holds 0.00 shares in Orchard Therapeutics (Ticker: ORTX), holds 534.76K shares in Generation Bio (Ticker: GBIO), holds 30.00K shares in Viking Therapeutics (Ticker: VKTX).
Profitable Transactions
6 out of 12 Profitable Transactions
Average Return
+12.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Charles Rowland holds in companies
Most Profitable Insider Trade
The most profitable trade made by Charles Rowland
Charles Rowland's Trading History
DNIB Unwind, Inc.
Aug 30, 2016
―
Informative Buy
6.60K
$0.00
Nabriva Therapeutics
Aug 03, 2022
Director
Informative Sell
1.44K
$3.09K
Viking Therapeutics
May 18, 2023
Director
Uninformative Buy
43.20K
$2.23M
Generation Bio
Dec 05, 2023
Director
Informative Buy
477.78K
$1.55M
Orchard Therapeutics
Jan 24, 2024
―
Uninformative Sell
―
$0.00
Vitae Pharma
―
―
―
$0.00
Blueprint Medicines
Jun 04, 2021
Director
Uninformative Buy
―
$540.52K
Viropharma
Jan 28, 2014
―
Uninformative Sell
4.35M
―
Idenix Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Charles Rowland's performance on stock
You May Also Like
Charles Rowland insider profile FAQ
What is the percentage of profitable transactions made by Charles Rowland?
The percentage of profitable transactions made by Charles Rowland is 50%.
What is the average return per transaction made by Charles Rowland?
The average return per transaction made by Charles Rowland is 12.40%.
What stocks does Charles Rowland hold?
Charles Rowland holds: BINDQ, NBRVF, VKTX, GBIO, ORTX, VTAE, BPMC, VPHM, IDIX stocks.
What was Charles Rowland’s latest transaction?
Charles Rowland latest transaction was an Uninformative Sell of ―.
What was Charles Rowland's most profitable transaction?
Charles Rowland’s most profitable transaction was an Informative Buy of GBIO stock on December 5, 2023. The return on the trade was 110.50%.
What is Charles Rowland's role in DNIB Unwind, Inc.?
Charles Rowland's role in DNIB Unwind, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.